SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-118626
Filing Date
2023-04-26
Accepted
2023-04-26 16:36:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d292357ddefa14a.htm DEFA14A 11359
2 GRAPHIC g292357dsp002.jpg GRAPHIC 298180
3 GRAPHIC g292357dsp003.jpg GRAPHIC 230828
  Complete submission text file 0001193125-23-118626.txt   741266
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39219 | Film No.: 23850345
SIC: 2836 Biological Products, (No Diagnostic Substances)